Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).

No abstract is available for this paper.

• Publication year

  2015

• Venue

  JACC. Heart failure

• Publication date

  2015-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jchf.2014.12.018PMID 25982111PMCID PMC4458213
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

  2014cited by this paper
• Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide.

  2014cited by this paper
• 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

  2014cited by this paper
• Net Reclassification Improvement: Computation, Interpretation, and Controversies

  2014cited by this paper
• A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.

  2013cited by this paper
• Abstract 16937: Initiation of Moderate Physical Activity Reduces Progression of Subclinical Cardiac Injury in Previously Sedentary Older Adults: Results From a Randomized Pilot Study of Exercise Intervention

  2013cited by this paper
• Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2013cited by this paper
• Predictors of New-Onset Heart Failure: Differences in Preserved Versus Reduced Ejection Fraction

  2013cited by this paper
• Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk.

  2013cited by this paper
• Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2013cited by this paper
• Contemporary Reviews in Cardiovascular Medicine The Progression of Hypertensive Heart Disease

  2011cited by this paper
• New targets to treat the structural remodeling of the myocardium.

  2011cited by this paper
• Diastolic and Systolic Heart Failure Are Distinct Phenotypes Within the Heart Failure Spectrum

  2011cited by this paper
• Systolic and Diastolic Heart Failure Are Overlapping Phenotypes Within the Heart Failure Spectrum

  2011cited by this paper
• ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology,

  2011cited by this paper
• Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.

  2010cited by this paper
• Analytical validation of a high-sensitivity cardiac troponin T assay.

  2010cited by this paper
• Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

  2010cited by this paper
• A 4-Tiered Classification of Left Ventricular Hypertrophy Based on Left Ventricular Geometry: The Dallas Heart Study

  2010cited by this paper
• Longitudinal Tracking of Left Ventricular Mass Over the Adult Life Course: Clinical Correlates of Short- and Long-Term Change in the Framingham Offspring Study

  2009cited by this paper
• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

  2008cited by this paper
• Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure

  2006cited by this paper
• Recommendations for chamber quantification.

  2006cited by this paper
• N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy

  2006cited by this paper
• Trends in prevalence and outcome of heart failure with preserved ejection fraction.

  2006cited by this paper
• Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.

  2004cited by this paper
• Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.

  2002cited by this paper
• Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study.

  2001cited by this paper
• A Proportional Hazards Model for the Subdistribution of a Competing Risk

  1999cited by this paper
• Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study.

  1995cited by this paper
• Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study.

  1995cited by this paper
• The Cardiovascular Health Study: design and rationale.

  1991cited by this paper
• Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

  1986cited by this paper
• Covariance analysis of censored survival data.

  1974cited by this paper

• Natriuretic peptides and cardiac troponins in hypertension and heart failure: A contemporary review of the evidence.

  2026cites this paper
• Left ventricular hypertrophy and myocardial fibrosis in heart failure with preserved ejection fraction: mechanisms and treatment

  2025cites this paper
• Hypertensive heart disease in older patients: considerations for clinical practice.

  2025cites this paper
• Hypertensive Heart Disease: A Narrative Review Series—Part 3: Vasculature, Biomarkers and the Matrix of Hypertensive Heart Disease

  2024influential citation
• Malignant Left Ventricular Hypertrophy and Risk of Cognitive Impairment in SPRINT MIND Trial.

  2024cites this paper
• Emerging therapies targeting cardiovascular risk factors to prevent or delay the onset of heart failure

  2024cites this paper
• Left ventricular hypertrophy phenotype to predict incident atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis.

  2024cites this paper
• Hypertensive heart disease: risk factors, complications and mechanisms

  2023cites this paper
• Autoantibodies against the chemokine receptor 3 predict cardiovascular risk

  2023cites this paper
• Predicting and preventing heart failure in type 2 diabetes.

  2023cites this paper
• Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic Cardiomyopathy

  2023cites this paper
• Sclareol attenuates angiotensin II‐induced cardiac remodeling and inflammation via inhibiting MAPK signaling

  2022cites this paper
• The Role of Biomarkers in Heart Failure with Preserved Ejection Fraction

  2022influential citation
• Malignant Left Ventricular Hypertrophy and Epidemiology 101.

  2022cites this paper
• Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy.

  2022cites this paper
• Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond

  2022cites this paper
• Myocardial injury in stress echocardiography: Comparison of dobutamine, dipyridamole and dynamic stressors–single center study

  2022cites this paper
• Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study

  2022cites this paper
• Asymptomatic Left Ventricular Hypertrophy Is a Potent Risk Factor for the Development of HFpEF but Not HFrEF: Results of a Retrospective Cohort Study

  2022cites this paper
• Biomarkers in Heart Failure with Preserved Ejection Fraction

  2022cites this paper
• Longitudinal changes in cardiac troponin and risk of heart failure among Black adults.

  2022cites this paper
• High-Sensitivity Troponin: A Review on Characteristics, Assessment, and Clinical Implications

  2022cites this paper
• Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population

  2021cites this paper
• Potential of valsartan+sacubitril therapy in hypertensive heart disease

  2021cites this paper
• Перспективы применения препарата валсартан+сакубитрил при гипертоническом сердце

  2021cites this paper
• Risk factors and prediction models for incident heart failure with reduced and preserved ejection fraction

  2021cites this paper
• Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure

  2020cites this paper
• A Contemporary Approach to Hypertensive Cardiomyopathy: Reversing Left Ventricular Hypertrophy

  2020cites this paper
• Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers

  2020cites this paper
• Heart Failure as a Consequence of Hypertension

  2020cites this paper
• Point-of-Care Testing Devices for Heart Failure Analyzing Blood and Saliva Samples

  2020cites this paper
• Hypertension and Heart Failure.

  2019influential citation
• Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study

  2019cites this paper
• Interactive role of diastolic dysfunction and ventricular remodeling in asymptomatic subjects at increased risk of heart failure

  2019cites this paper
• Limited contribution of left ventricular mass and remodelling to the impact of blood pressure on diastolic function in a community sample

  2019cites this paper
• Visual and measured clinical phenotypes: Potential targets for cardiovascular prevention

  2019cites this paper
• The Heart in Childhood Hypertension

  2019cites this paper
• Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients

  2019cites this paper
• Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy

  2019cites this paper
• Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA

  2018influential citation
• Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction

  2018cites this paper
• Myocardial Remodeling in Hypertension: Toward a New View of Hypertensive Heart Disease

  2018cites this paper
• Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction

  2018cites this paper
• “Malignant” Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi‐Ethnic Study of Atherosclerosis)

  2018cites this paper
• Combination of Plasma Biomarkers and Clinical Data for the Detection of Myocardial Fibrosis or Aggravation of Heart Failure Symptoms in Heart Failure with Preserved Ejection Fraction Patients

  2018cites this paper
• High-Sensitivity Cardiac Troponin and New-Onset Heart Failure: A Systematic Review and Meta-Analysis of 67,063 Patients With 4,165 Incident Heart Failure Events.

  2018influential citation
• Invited Commentary: Searching for the Perfect Measure of Diastolic Dysfunction-A Futile Exercise?

  2017cites this paper
• Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction: The Health ABC Study (Health, Aging, and Body Composition)

  2017cites this paper
• The Transition From Hypertension to Heart Failure: Contemporary Update.

  2017cites this paper
• Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association

  2017cites this paper
• Arterial Stiffness and risk of Overall Heart Failure, Heart Failure with Preserved Ejection Fraction, and Heart Failure with Reduced Ejection Fraction: The Health ABC Study

  2017cites this paper
• Syddansk Universitet The interplay between fasting glucose , echocardiography , and biomarkers Pathophysiological considerations and prognostic implications

  2017cites this paper
• The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.

  2017influential citation
• Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction

  2017influential citation
• Arterial Stiffness and Risk of Overall Heart Failure , Heart Failure With Preserved Ejection Fraction , and Heart Failure With Reduced Ejection Fraction

  2017cites this paper
• Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation.

  2016cites this paper
• Fibroblast Growth Factor-23 and Cardiac Magnetic Resonance Indices of Myocardial Fibrosis in the Multi-Ethnic Study of Atherosclerosis

  2016cites this paper
• Use of cTn for Detection of More Chronic Disease States

  2016cites this paper
• Differential diagnosis and clinical management of diastolic heart failure: current best practice

  2016cites this paper
• Impact of Race, Ethnicity, and Multimodality Biomarkers on the Incidence of New-Onset Heart Failure With Preserved Ejection Fraction (from the Multi-Ethnic Study of Atherosclerosis).

  2016influential citation
• Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers

  2016cites this paper
• Dynamic Changes in High‐Sensitivity Cardiac Troponin I Are Associated with Dynamic Changes in Sum Absolute QRST Integral on Surface Electrocardiogram in Acute Decompensated Heart Failure

  2016cites this paper
• Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes

  2016cites this paper
• Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic

  2016cites this paper
• Troponin in Cardiovascular Disease Prevention: Updates and Future Direction

  2016cites this paper
• Biomarkers in heart failure with preserved ejection fraction

  2016cites this paper
• Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.

  2016cites this paper
• Left Ventricular Hypertrophy in Asymptomatic Nonsevere Aortic Stenosis: Should We Worry?

  2015cites this paper
• Biomarker Testing and Pre-emptive Therapy in Preventing Heart Failure

  2015cites this paper
• The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management

  2015influential citation
• Predicting Heart Failure Phenotypes using Cardiac Biomarkers: Hype and Hope

  2015cites this paper
• Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use

  2015cites this paper
• Predict, Protect, Prevent: Working Toward a Personalized Approach to Heart Failure Prevention.

  2015cites this paper